Retail store Walmart Inc (NYSE:WMT) on Thursday launched a series of community events to administer the COVID-19 vaccine across the country in partnership with local community leaders and nonprofit organizations and under CDC vaccine allocation.
Through the Federal Retail Pharmacy Programme, the company has announced ongoing community vaccination programme at 1,400 pharmacies nationwide in 35 states, Puerto Rico and Washington, DC. Vaccine supply and eligibility will vary based on state and local guidelines. The eligible customers can schedule a vaccine appointment at http://www.walmart.com/COVIDvaccine.
The community vaccine events will take place at 43 locations across 18 states, including drive-thru locations in Walmart parking lots, in-store and across several offsite locations in partnership with community organizations.
In addition, the company plans to continue these new events in Alabama, Colorado, Florida, Georgia, Idaho, Indiana, Louisiana, Minnesota, Mississippi, Missouri, Nevada, Oklahoma, Pennsylvania, South Dakota, Tennessee, Texas, Utah and Virginia.
Circio unveils circVec proof-of-concept
GSK releases decade-long data on Shingrix efficacy
BiVictriX receives FDA Orphan Drug Designation for AML treatment candidate
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Amneal announces launch of PEMRYDI RTU, a ready-to-use oncology injectable
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
GSK's meningitis vaccine candidate accepted for FDA review
Medivir and Vetbiolix report positive results from VBX-1000 Proof-of-Concept clinical study
Norgine submits first marketing authorisation application submissions for approval of eflornithine
Innovent Biologics names new Oncology CMO
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
ProAxsis secures GBP1.8m investment
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients